Private Label Peptide Squalane Facial Oil Manufacturer Low MOQ

What regulations apply to selling a peptide squalane facial oil in the US and EU?

By Blake Mereby · Last reviewed October 12, 2026

Peptide squalane facial oils are regulated as cosmetics — not drugs — in both the US and EU, provided you make only cosmetic-level claims. The regulatory burden is meaningfully different between the two markets, so it is worth understanding both if you have any international ambitions.

United States (FDA / MoCRA): The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) introduced the most significant changes to US cosmetic regulation in decades. As of late 2023 and 2024, any company that manufactures or processes cosmetics for sale in the US must register its facility with the FDA and list each cosmetic product, including its complete ingredient list. For brands that contract manufacture, the obligation falls on the facility doing the actual manufacturing — but you as the brand owner are still responsible for ensuring your contract manufacturer is registered. Failure to comply can result in import holds or mandatory recalls.

MoCRA also requires that brands have a mechanism for adverse event reporting and that they maintain safety substantiation for each product. For a simple anhydrous squalane oil, substantiation typically means a Cosmetic Product Safety Assessment prepared by a qualified cosmetic chemist or toxicologist, reviewing each ingredient at its used concentration against established safety databases (CIR, SCCS opinions, RIFM data for any fragrance components).

Claims are the most common regulatory tripwire. Saying your oil "plumps and firms skin" is a cosmetic claim. Saying it "stimulates collagen synthesis" or "reverses photoaging" starts to sound like a drug claim and can trigger FDA enforcement. Stick to appearance-based, non-mechanistic language.

European Union (EC 1223/2009): EU cosmetics regulation is more prescriptive than the US equivalent. Before placing your product on the EU market you must: appoint an EU Responsible Person (an individual or entity physically based in the EU who holds the Product Information File); prepare a PIF that includes the cosmetic product safety report (Part A and Part B, the latter requiring a qualified Safety Assessor); ensure INCI labeling in full, in descending order of concentration, with mandatory warnings, PAO or minimum durability date, and net weight; and notify the product through the EU Cosmetic Products Notification Portal (CPNP).

Californnia Proposition 65: If you sell in California, verify that no ingredients in your formula appear on the Prop 65 list. For a straightforward peptide squalane oil using plant-derived squalane and established cosmetic peptides, the risk is generally low — but check any fragrance components or colorants you include.

Important regional note for the UK post-Brexit: Great Britain now operates its own cosmetic regulation (UK Cosmetics Regulation SI 2019/696), which mirrors EU regulation but requires a separate UK Responsible Person and UK CPNP notification through the Office for Product Safety and Standards (OPSS). Northern Ireland remains aligned with EU rules.

AJ Cosmo Labs connects you with formulators who understand these regulatory lanes and can flag compliance gaps early in the project — before you've committed to a packaging run or a production batch that doesn't meet labeling requirements.

Ingredients in this answer: Squalane

Read the full guide on Private Label Peptide Squalane Facial Oil Manufacturer Low MOQ →

More about Private Label Peptide Squalane Facial Oil Manufacturer Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app